| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FX20 | BioTech | Tremelimumab - 25mg/1.25ml | 12571 | 39823/1 | IMJUDO | 25mg/1.25ml | 1x1.25ml | Injectable solution | Infusion | Omnipharma | Vetter Pharma- Fertigung GmbH & Co KG | Germany | 141,444,422 L.L | 2.44 | E2 | AstraZeneca AB | Sweden | 6/3/2026 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FX20 | BioTech | Tremelimumab - 300mg/15ml | 12572 | 39723/1 | IMJUDO | 300mg/15ml | 1x15ml | Injectable solution | Infusion | Omnipharma | Vetter Pharma- Fertigung GmbH & Co KG | Germany | 1,487,881,996 L.L | 2.44 | E2 | AstraZeneca AB | Sweden | 6/3/2026 |

